Genome-wide screen yields new gene therapies to protect against retinal degeneration

Researchers in the WashU Medicine Department of Ophthalmology & Visual Sciences have discovered key neuroprotective genes that could lead to the development of gene therapies to treat retinitis pigmentosa, an inherited form of retinal degeneration that causes blindness. The findings, published in Neuron, point to new therapeutic strategies to maintain retinal health and protect against degeneration.